Results 181 to 190 of about 16,160 (262)

Socioclinical profile of patients submitted to corneal transplantation in a reference hospital

, 2022
Amanda Vallinoto Silva de Araújo, Clara Godinho Marinho, Fernanda do Socorro Rocha Rodrigues, Matheus Sousa Alves, Oswaldo Cardoso Frazão Neto   +4 more
openalex   +1 more source

Treatment of donor corneal tissue with immunomodulatory cytokines: a novel strategy to promote graft survival in high-risk corneal transplantation [PDF]

, 2017
Maryam Tahvildari, Parisa Emami-Naeini, Masahiro Omoto, Alireza Mashaghi, Sunil K. Chauhan, Reza Dana   +5 more
openalex   +1 more source

Central nervous system involvement in cardiac amyloidosis: Redefining the heart‐brain axis

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Central nervous system involvement in cardiac amyloidosis. Amyloidosis is a systemic disease that can directly affect the central nervous system. Furthermore, the amyloid cardiomyopathy can indirectly affect the central nervous system by inducing systemic hypoperfusion and increasing the risk of acute ischaemic stroke.
Domenico Mario Giamundo, Giuliano Cassataro, Stefano Ministrini, Simon F. Stämpfli   +3 more
wiley   +1 more source

Clinical manifestations and outcomes of HSK following corneal transplantation [PDF]

Dan Wu, Hui Huang, Min Zheng, Qi Chen, Zhou Zhou, Jiang Li, Yuanhua Li, Yiyun Liu, Baoyou Ma, Guoqing Chen, Yujun Huang, Fengping Cen, Binghua Chen, Fengmei Li, Hong Qi, Fan Xu, Qianqian Lan   +16 more
openalex   +1 more source

Long‐term effectiveness and safety outcomes in adults with Fabry disease treated with agalsidase alfa: 20 years of data from the Fabry Outcome Survey

European Journal of Clinical Investigation, Volume 56, Issue 1, January 2026.
Long‐term treatment with agalsidase alfa in 1864 adults with Fabry disease in the Fabry Outcome Survey confirmed previously reported beneficial effects on renal function and cardiomyopathy. Over a median (min, max) of 6.0 (0, 21.6) years of treatment, annualized changes in eGFR remained relatively stable in females and declined slightly in males.
Derralynn A. Hughes, Guillem Pintos‐Morell, Christoph Kampmann, Christina Anagnostopoulou, Jaco Botha, Siddharth Jain, Kathleen Nicholls, Dau‐Ming Niu, Ricardo Reisin, Michael L. West, Jörn Schenk, Uma Ramaswami, Roberto Giugliani   +12 more
wiley   +1 more source

Corneal transplantation in the United Kingdom and Republic of Ireland. [PDF]

, 1993
Andy Vail, S M Gore, B Bradley, D L Easty, Chris Rogers   +4 more
openalex   +1 more source

Safety and Efficacy of Vadadustat Versus Darbepoetin Alfa for Chronic Kidney Disease–Related Anemia in Patients Receiving Dialysis by Baseline Erythropoiesis‐Stimulating Agent Dose

Hemodialysis International, Volume 30, Issue 1, Page 80-100, January 2026.
ABSTRACT Introduction Erythropoiesis‐stimulating agents (ESAs) and iron supplementation are standard treatments for chronic kidney disease (CKD)–related anemia. Targeting higher hemoglobin values in CKD increases cardiovascular risk. Whether the increased risk is from higher ESA doses or higher hemoglobin levels is uncertain, but alternative therapies ...
Alan Jardine, Steven K. Burke, Wenli Luo, Todd Minga, Mark J. Sarnak, Wolfgang C. Winkelmayer, Rajiv Agarwal, Glenn M. Chertow, Kai‐Uwe Eckardt, Mark J. Koury   +9 more
wiley   +1 more source

Use of porcine small intestinal submucosa for reconstruction of a soft palate defect following marginal resection of a melanoma in a dog

Journal of Small Animal Practice, Volume 67, Issue 1, Page 92-96, January 2026.
A 12‐year‐old castrated male golden retriever was referred for evaluation of a palatal mass. Computed tomography identified a 2.7 × 2.0 × 1.5 cm soft tissue mass extending from the caudal aspect of the hard palate to the rostral soft palate. Bilateral caudal maxillectomy was declined by owners; thus, a marginal resection was performed.
M. A. Walker, N. Bacon, K. L. Hoddinott
wiley   +1 more source

Emerging Frontiers in Clinical Mycology: Innovations, Insights, and Impacts

Mycoses, Volume 69, Issue 1, January 2026.
ABSTRACT The Mycoses Study Group Education and Research Consortium (MSGERC)—a group comprising clinicians, researchers, patients, and industry partners—meets every 2 years to review the most significant challenges facing the clinical mycology community and plan research, education, and advocacy strategies to prevent fungal infections and improve ...
A. Apostolopoulou, A. G. Stewart, H. Yoon, J. M. Steinbrink, D. Z. P. Friedman, L. Ostrosky‐Zeichner, I. S. Schwartz, on behalf of the Mycoses Study Group Education and Research Consortium (MSGERC)   +7 more
wiley   +1 more source